BUSINESS● LOWSep 21 · Sep 21, 2026, 8:31 AM
Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs
CNBC · global
The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS31m agoTop bankers to gather in Hong Kong to learn how the city has been ‘rethinking the playbook’South China Morning PostBUSINESS31m agoSouth Korea urged to guard chip profitability as China’s CXMT and YMTC gain market shareSouth China Morning Post